Back to Journals » Cancer Management and Research
Cancer Management and Research
Editor-in-Chief: Professor Yong Teng
Cancer Management and Research is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team.
An international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (5178)
- Volume 18, 2026 (144)
- Volume 17, 2025 (276)
- Volume 16, 2024 (164)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Latest articles:
- 5 records -
PET-MR Examination in Diagnosing Bone Metastases in Prostate Cancer
Su X, Li K, Wang J, Jiang Z, Shan L
Cancer Management and Research 2026, 18:572865
Published Date: 19 June 2026
Early versus Long-Term Post-Prostatectomy Incontinence Recovery Among Three Robotic-Assisted Radical Prostatectomy Techniques: A Retrospective Cohort Study
Lin SH, Lin PH, Chao DY, Wu CT, Shao IH
Cancer Management and Research 2026, 18:604780
Published Date: 18 June 2026
Exploratory Pilot Multi-Omics Profiling of Gut Microbiota and Metabolic Features in Patients with Prolactinoma
Yang J, Nie D, Zhang Y, Li C
Cancer Management and Research 2026, 18:608026
Published Date: 16 June 2026
Berberine from Tibetan Medicine Dracocephalum tanguticum Maxim Suppresses Colorectal Tumor Growth and Inhibits CD8⁺ T Cells Ferroptosis via the NRF2–SLC7A11–GPX4 Axis
Wang Y, Zhang Y, Wang Q, Zheng L, Liu Y
Cancer Management and Research 2026, 18:600327
Published Date: 16 June 2026
CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
Liu J, Liu Y, Du Y, Sun G
Cancer Management and Research 2026, 18:611187
Published Date: 15 June 2026